The human intestinal fatty acid binding protein (hFABP2) gene is regulated by HNF-4α

Biochemical and Biophysical Research Communications

Volumn 356, Issue 1, 2007, Pages 147-152

  Klapper, Maja ^a   Böhme, Mike ^a   Nitz, Inke ^a   Döring, Frank ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

EMSA; Fatty acid metabolism; hFABP2; HNF 4 ; Reporter assay

Indexed keywords

FATTY ACID BINDING PROTEIN; FATY ACID BINDING PROTEIN 2; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; LONG CHAIN FATTY ACID; LUCIFERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL STRAIN CACO 2; CONTROLLED STUDY; CYTOSOL; ENDODERM; FAT INTAKE; FATTY ACID METABOLISM; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENE CONTROL; GENETIC TRANSCRIPTION; GENOTYPE; HELA CELL; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REPORTER GENE;

BASE SEQUENCE; BINDING SITES; CACO-2 CELLS; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FATTY ACID-BINDING PROTEINS; GENE EXPRESSION REGULATION; HELA CELLS; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; LUCIFERASES; MUTATION; OLIGONUCLEOTIDES; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; TRANSFECTION;

EID: 33947115283     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.02.091     Document Type: Article

References (41)

1. Sweetser D.A., Birkenmeier E.H., Klisak I.J., Zollman S., Sparkes R.S., Mohandas T., Lusis A.J., and Gordon J.I. The human and rodent intestinal fatty acid binding protein genes. A comparative analysis of their structure, expression, and linkage relationships. J. Biol. Chem. 262 (1987) 16060-16071
2. Sweetser D.A., Hauft S.M., Hoppe P.C., Birkenmeier E.H., and Gordon J.I. Transgenic mice containing intestinal fatty acid-binding protein-human growth hormone fusion genes exhibit correct regional and cell-specific expression of the reporter gene in their small intestine. Proc. Natl. Acad. Sci. USA 85 (1988) 9611-9615
3. Cohn S.M., Simon T.C., Roth K.A., Birkenmeier E.H., and Gordon J.I. Use of transgenic mice to map cis-acting elements in the intestinal fatty acid binding protein gene (Fabpi) that control its cell lineage-specific and regional patterns of expression along the duodenal-colonic and crypt-villus axes of the gut epithelium. J. Cell Biol. 119 (1992) 27-44
4. Gordon J.I., Elshourbagy N., Lowe J.B., Liao W.S., Alpers D.H., and Taylor J.M. Tissue specific expression and developmental regulation of two genes coding for rat fatty acid binding proteins. J. Biol. Chem. 260 (1985) 1995-1998
5. Shields H.M., Bates M.L., Bass N.M., Best C.J., Alpers D.H., and Ockner R.K. Light microscopic immunocytochemical localization of hepatic and intestinal types of fatty acid-binding proteins in rat small intestine. J. Lipid Res. 27 (1986) 549-557
6. Haegebarth A., Bie W., Yang R., Crawford S.E., Vasioukhin V., Fuchs E., and Tyner A.L. Protein tyrosine kinase 6 negatively regulates growth and promotes enterocyte differentiation in the small intestine. Mol. Cell Biol. 26 (2006) 4949-4957
7. Lowe J.B., Sacchettini J.C., Laposata M., McQuillan J.J., and Gordon J.I. Expression of rat intestinal fatty acid-binding protein in Escherichia coli. Purification and comparison of ligand binding characteristics with that of Escherichia coli-derived rat liver fatty acid-binding protein. J. Biol. Chem. 262 (1987) 5931-5937
8. Levy E., Menard D., Delvin E., Stan S., Mitchell G., Lambert M., Ziv E., Feoli-Fonseca J.C., and Seidman E. The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants. J. Biol. Chem. 276 (2001) 39679-39684
9. Baier L.J., Bogardus C., and Sacchettini J.C. A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J. Biol. Chem. 271 (1996) 10892-10896
10. Odom D.T., Zizlsperger N., Gordon D.B., Bell G.W., Rinaldi N.J., Murray H.L., Volkert T.L., Schreiber J., Rolfe P.A., Gifford D.K., Fraenkel E., Bell G.I., and Young R.A. Control of pancreas and liver gene expression by HNF transcription factors. Science 303 (2004) 1378-1381
11. Stegmann A., Hansen M., Wang Y., Larsen J.B., Lund L.R., Ritie L., Nicholson J.K., Quistorff B., Simon-Assmann P., Troelsen J.T., and Olsen J. Metabolome, transcriptome, and bioinformatic cis-element analyses point to HNF-4 as a central regulator of gene expression during enterocyte differentiation. Physiol. Genomics 27 (2006) 141-155
12. Olsen L., Bressendorff S., Troelsen J.T., and Olsen J. Differentiation-dependent activation of the human intestinal alkaline phosphatase promoter by HNF-4 in intestinal cells. Am. J. Physiol. Gastrointest. Liver Physiol. 289 (2005) G220-G226
13. Hu C., and Perlmutter D.H. Regulation of alpha1-antitrypsin gene expression in human intestinal epithelial cell line caco-2 by HNF-1alpha and HNF-4. Am. J. Physiol. 276 (1999) G1181-G1194
14. Hertz R., Magenheim J., Berman I., and Bar-Tana J. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha. Nature 392 (1998) 512-516
15. Sheena V., Hertz R., Nousbeck J., Berman I., Magenheim J., and Bar-Tana J. Transcriptional regulation of human microsomal triglyceride transfer protein by hepatocyte nuclear factor-4alpha. J. Lipid Res. 46 (2005) 328-341
16. Ladias J.A., Hadzopoulou-Cladaras M., Kardassis D., Cardot P., Cheng J., Zannis V., and Cladaras C. Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2, and EAR-3. J. Biol. Chem. 267 (1992) 15849-15860
17. Ginsburg G.S., Ozer J., and Karathanasis S.K. Intestinal apolipoprotein AI gene transcription is regulated by multiple distinct DNA elements and is synergistically activated by the orphan nuclear receptor, hepatocyte nuclear factor 4. J. Clin. Invest. 96 (1995) 528-538
18. Archer A., Sauvaget D., Chauffeton V., Bouchet P.E., Chambaz J., Pincon-Raymond M., Cardot P., Ribeiro A., and Lacasa M. Intestinal apolipoprotein A-IV gene transcription is controlled by two hormone-responsive elements: a role for hepatic nuclear factor-4 isoforms. Mol. Endocrinol. 19 (2005) 2320-2334
19. Carriere V., Vidal R., Lazou K., Lacasa M., Delers F., Ribeiro A., Rousset M., Chambaz J., and Lacorte J.M. HNF-4-dependent induction of apolipoprotein A-IV gene transcription by an apical supply of lipid micelles in intestinal cells. J. Biol. Chem. 280 (2005) 5406-5413
20. Li Y., Fisher E., Klapper M., Boeing H., Pfeiffer A., Hampe J., Schreiber S., Burwinkel B., Schrezenmeir J., and Doring F. Association between functional FABP2 promoter haplotype and type 2 diabetes. Horm. Metab. Res. 38 (2006) 300-307
21. Nitz I., Doring F., Schrezenmeir J., and Burwinkel B. Identification of new acyl-CoA binding protein transcripts in human and mouse. Int. J. Biochem. Cell Biol. 37 (2005) 2395-2405
22. Kel A.E., Gossling E., Reuter I., Cheremushkin E., Kel-Margoulis O.V., and Wingender E. MATCH: a tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res. 31 (2003) 3576-3579
23. Matys V., Kel-Margoulis O.V., Fricke E., Liebich I., Land S., Barre-Dirrie A., Reuter I., Chekmenev D., Krull M., Hornischer K., Voss N., Stegmaier P., Lewicki-Potapov B., Saxel H., Kel A.E., and Wingender E. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res. 34 (2006) D108-D110
24. Rottman J.N., and Gordon J.I. Comparison of the patterns of expression of rat intestinal fatty acid binding protein/human growth hormone fusion genes in cultured intestinal epithelial cell lines and in the gut epithelium of transgenic mice. J. Biol. Chem. 268 (1993) 11994-12002
25. Hatzis P., and Talianidis I. Dynamics of enhancer-promoter communication during differentiation-induced gene activation. Mol. Cell 10 (2002) 1467-1477
26. Chantret I., Barbat A., Dussaulx E., Brattain M.G., and Zweibaum A. Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines. Cancer Res. 48 (1988) 1936-1942
27. Duncan S.A., Navas M.A., Dufort D., Rossant J., and Stoffel M. Regulation of a transcription factor network required for differentiation and metabolism. Science 281 (1998) 692-695
28. Kardassis D., Falvey E., Tsantili P., Hadzopoulou-Cladaras M., and Zannis V. Direct physical interactions between HNF-4 and Sp1 mediate synergistic transactivation of the apolipoprotein CIII promoter. Biochemistry 41 (2002) 1217-1228
29. Divine J.K., McCaul S.P., and Simon T.C. HNF-1alpha and endodermal transcription factors cooperatively activate Fabpl: MODY3 mutations abrogate cooperativity. Am. J. Physiol. Gastrointest. Liver Physiol. 285 (2003) G62-G72
30. Rowley C.W., Staloch L.J., Divine J.K., McCaul S.P., and Simon T.C. Mechanisms of mutual functional interactions between HNF-4alpha and HNF-1alpha revealed by mutations that cause maturity onset diabetes of the young. Am. J. Physiol. Gastrointest. Liver Physiol. 290 (2006) G466-G475
31. Harnish D.C., Malik S., Kilbourne E., Costa R., and Karathanasis S.K. Control of apolipoprotein AI gene expression through synergistic interactions between hepatocyte nuclear factors 3 and 4. J. Biol. Chem. 271 (1996) 13621-13628
32. Nakshatri H., and Bhat-Nakshatri P. Multiple parameters determine the specificity of transcriptional response by nuclear receptors HNF-4, ARP-1, PPAR, RAR and RXR through common response elements. Nucleic Acids Res. 26 (1998) 2491-2499
33. Mangelsdorf D.J., and Evans R.M. The RXR heterodimers and orphan receptors. Cell 83 (1995) 841-850
34. Damcott C.M., Feingold E., Moffett S.P., Barmada M.M., Marshall J.A., Hamman R.F., and Ferrell R.E. Variation in the FABP2 promoter alters transcriptional activity and is associated with body composition and plasma lipid levels. Hum. Genet. 112 (2003) 610-616
35. Formanack M.L., and Baier L.J. Variation in the FABP2 promoter affects gene expression: implications for prior association studies. Diabetologia 47 (2004) 349-351
36. Geschonke K., Klempt M., Lynch N., Schreiber S., Fenselau S., and Schrezenmeir J. Detection of a promoter polymorphism in the gene of intestinal fatty acid binding protein (I-FABP). Ann. NY Acad. Sci. 967 (2002) 548-553
37. Dube N., Delvin E., Yotov W., Garofalo C., Bendayan M., Veerkamp J.H., and Levy E. Modulation of intestinal and liver fatty acid-binding proteins in Caco-2 cells by lipids, hormones and cytokines. J. Cell Biochem. 81 (2001) 613-620
38. Chiu K.C., Chuang L.M., and Yoon C. The A54T polymorphism at the intestinal fatty acid binding protein 2 is associated with insulin resistance in glucose tolerant Caucasians. BMC Genet. 2 (2001) 7
39. Galluzzi J.R., Cupples L.A., Meigs J.B., Wilson P.W., Schaefer E.J., and Ordovas J.M. Association of the Ala54-Thr polymorphism in the intestinal fatty acid-binding protein with 2-h postchallenge insulin levels in the Framingham offspring study. Diabetes Care 24 (2001) 1161-1166
40. Yamada K., Yuan X., Ishiyama S., Koyama K., Ichikawa F., Koyanagi A., Koyama W., and Nonaka K. Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia 40 (1997) 706-710
41. Silander K., Mohlke K.L., Scott L.J., Peck E.C., Hollstein P., Skol A.D., Jackson A.U., Deloukas P., Hunt S., Stavrides G., Chines P.S., Erdos M.R., Narisu N., Conneely K.N., Li C., Fingerlin T.E., Dhanjal S.K., Valle T.T., Bergman R.N., Tuomilehto J., Watanabe R.M., Boehnke M., and Collins F.S. Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes. Diabetes 53 (2004) 1141-1149